A concentration-response curve can reflect more than an agonist’s nominal concentration because receptor affinity influences how strongly the compound engages its receptor. Receptor coupling and downstream cellular signaling also shape the observed response. Consequently, potency measured in one receptor or cell system may not represent the same activity in another experimental context.
Receptor coupling helps determine how effectively receptor engagement is translated into a biological response. Two agonists with activity at the same receptor can therefore produce different measured potency values if their receptor interactions connect differently with cellular signaling processes. This makes coupling an important consideration when interpreting concentration-response results and comparing compounds across experimental systems.
Potency and efficacy describe different features of agonist activity. Potency concerns the concentration or dose associated with a specified response, whereas efficacy concerns the maximum response the agonist can produce. A compound can therefore act at a lower concentration yet produce a smaller maximum effect than another compound, so potency alone cannot identify the most effective agonist.
Researchers determine potency by examining the relationship between agonist concentration and biological response. The concentration-response curve provides an EC50 value, which identifies the concentration producing half of the maximal response under the tested conditions. This approach converts the experimental response pattern into a quantitative measure that can be used to characterize drug activity.
Comparing potency values across compounds helps researchers characterize receptor pharmacology and determine how drug activity differs under comparable experimental conditions. The comparison can reveal which compounds produce a specified response at lower or higher concentrations. Interpreting those differences alongside efficacy prevents researchers from treating a potency advantage as evidence of a greater maximum effect.
During lead optimization, potency comparisons help researchers prioritize compounds for further investigation and refine their understanding of receptor-directed activity. Potency measurements also help anticipate concentration ranges for subsequent preclinical or clinical evaluation. Because receptor coupling and cellular signaling influence measured values, these decisions require attention to the experimental system in which potency was determined.